Schizophr Res
Bipolar DisorderDendritesDisease Models, Animal
Dr. Glenn Konopaske, MD
NPI1386613354PAC ID3779474200
- Medicare services, 2024
- 58
- Medicare patients, 2024
- 52
- Part D claims, 2024
- 264
- Publications
- 12
- Clinical trials
- 1
- Practice address
- 263 Farmington Ave, Farmington, CT 06030
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD
Childrens Hospital outpatient department · Farmington, Connecticut
Find Dr. Konopaske's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Glenn Konopaske is a psychiatrist in Farmington, Connecticut
Dr. Konopaske practices at Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut.
Dr. Konopaske's NPI, 1386613354, was assigned on March 14, 2006. Dr. Konopaske graduated from University of Connecticut School of Medicine in 1999. Dr. Konopaske holds Connecticut license 40112.
NPI and contact details
- NPI
- 1386613354NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3779474200
- NPI enumeration date
- March 14, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 53
- Medical school graduation
- 1999
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Glenn Konopaske practices at Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut
Dr. Konopaske's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD, at 263 Farmington Ave, Farmington, CT 06030.
- Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD263 Farmington Ave, Farmington, CT 06030
Source: Dmand AI Affiliation Data
Dr. Glenn Konopaske is affiliated with 4 sites of care and 4 medical groups
Dr. Konopaske's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut. Dr. Konopaske is also affiliated with UConn John Dempsey Hospital. The medical group on file is UConn Medical Group. Dmand AI also links Dr. Konopaske to 3 more medical groups and 2 group practices and clinics, each named with a free account.
Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPDPrimary
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Glenn Konopaske's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Konopaske practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD | Available with a free account |
| +3 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Konopaske practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Glenn Konopaske is one of 828 psychiatrists in Connecticut
Psychiatry is Dr. Konopaske's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Konopaske is licensed in Connecticut.
Specialties and state licenses
- Psychiatry, ConnecticutPrimary
Psychiatrists near Dr. Konopaske
Counts of psychiatrists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Glenn Konopaske billed Medicare for 58 services in 2024
CMS data shows 58 Medicare services from Dr. Konopaske across 2 procedure codes in 2024, for 52 Medicare patients. Medicare paid $3,612 for them.
Medicare services, 202458
Medicare patients52
Paid by Medicare$3,612
Procedure codes2
Dr. Konopaske's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 182024: 58222%
Where Dr. Konopaske's Medicare services took place, 2024
- In an office4578%
- In a facility1322%
Dr. Konopaske compared with the Connecticut median for psychiatrists, 2024
- Dr. Konopaske
- Connecticut median
- Medicare services
- 58vs 11148% below
- Medicare patients
- 52vs 4030% above
- Part D claims
- 163vs 14215% above
Medians across 886 psychiatrists in Connecticut with Dmand AI profiles that report each measure.
Dr. Konopaske's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Konopaske?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Konopaske and other psychiatrists in Connecticut.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Glenn Konopaske treated 52 Medicare patients in 2024, average age 62
CMS counts 52 Medicare patients who saw Dr. Konopaske in 2024. The largest group is under 65, with 24 patients. 75% of them have anxiety, and 75% have depression. 58% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Konopaske's median patient age at 54, with 55% women.
Medicare patients, 202452
Average age62
Average risk score1.27
Also on Medicaid58%
Dr. Konopaske's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Konopaske's Medicare patients by sex, 2024
- Women2446%
- Men2854%
Chronic conditions among Dr. Konopaske's Medicare patients, 2024
- Anxiety75%
- Depression75%
- Mood disorders75%
- High blood pressure58%
- High cholesterol58%
- Schizophrenia and other psychoses50%
- Bipolar disorder37%
- Diabetes31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Konopaske's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 54
Patient panel by sex, all payers
- Women55%
- Men42%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Glenn Konopaske wrote 264 Medicare Part D claims in 2024
In 2024, Dr. Konopaske wrote 264 Medicare Part D claims for 56 patients. 94% of them were for generic drugs. CMS names the drug for 163 of them, across 8 drugs with 11 or more claims each, at $16,709 in total drug cost. In 2023, CMS named 86 claims across 6 drugs.
Part D claims, 2024264
Drugs named by CMS8
Total drug cost$16,709
Part D patients56
Dr. Konopaske's Part D claims by kind of drug, 2024
- Generic248 claims94%
- Brand-name16 claims6%
Dr. Konopaske's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Konopaske's Part D claims, 2024
- Antipsychotics, patients 65 and over5%14 of 264 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 862024: 16390%
Drugs named by CMS: 8 in 2024, 6 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Glenn Konopaske offers telehealth to Medicare patients
Dr. Konopaske accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Konopaske as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find psychiatrists like Dr. Konopaske by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Glenn Konopaske has 12 publications on record
Dmand AI links 12 papers to Dr. Konopaske, published from 2013 to 2018. The most frequent topics are Schizophrenia, Bipolar Disorder and Glutamic Acid. Dr. Konopaske has published most often in JAMA Psychiatry. Dr. Konopaske's most frequent co-authors are Rakesh Karmacharya, MD, PhD, Perry Franklin Renshaw, MD, PhD and Evan Yale Snyder, MD, PhD.
Papers12
Years published2013 to 2018
Dr. Konopaske's papers by year, 2013 to 2018
Topics Dr. Konopaske writes about most
- Schizophrenia
- Bipolar Disorder
- Glutamic Acid
- Nerve Tissue Proteins
- Antipsychotic Agents
- Gene Expression Regulation
- Magnetic Resonance Imaging
- Magnetic Resonance Spectroscopy
Dr. Konopaske's most frequent co-authors
- Rakesh Karmacharya, MD, PhD1 shared paper
- Perry Franklin Renshaw, MD, PhD1 shared paper
- Evan Yale Snyder, MD, PhD1 shared paper
Recent publications by Dr. Konopaske
Proc Natl Acad Sci U S A
Bipolar DisorderBrain ChemistryCalcium
Analysis of VarianceAntipsychotic AgentsBipolar Disorder
Behavior, AnimalBrainCognition Disorders
Psychopharmacology (Berl)
Antipsychotic AgentsAstrocytesChromatography, High Pressure Liquid
See who Dr. Konopaske researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Konopaske works with, so you can find a warm path to the right psychiatrists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Glenn Konopaske has worked on 1 clinical trial
Dmand AI links Dr. Konopaske to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Huntington Disease and Chorea.
Conditions in Dr. Konopaske's trials
- Huntington Disease
- Chorea
Investigators on the most trials with Dr. Konopaske
Recent clinical trials with Dr. Konopaske
Huntington DiseaseChorea
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Glenn Konopaske received $18 in industry payments in 2016
CMS Open Payments shows 1 general payment to Dr. Konopaske from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $18.
Companies that paid Dr. Konopaske the most, 2016 to 2016
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Glenn Konopaske graduated from University of Connecticut School of Medicine
Dr. Konopaske graduated from University of Connecticut School of Medicine in 1999.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Glenn Konopaske's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Glenn Konopaske
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Glenn Konopaske's NPI number?
Dr. Glenn Konopaske's NPI number is 1386613354. It was assigned on March 14, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Glenn Konopaske?
Dr. Glenn Konopaske is a psychiatrist in Farmington, Connecticut. The primary specialty in the NPI Registry is Psychiatry Physician (taxonomy code 2084P0800X).
Where does Dr. Glenn Konopaske practice?
Dr. Konopaske practices at 263 Farmington Ave, Farmington, CT 06030. Dr. Konopaske's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut. Dmand AI also links Dr. Konopaske to 3 medical groups and 2 group practices and clinics.
What is Dr. Glenn Konopaske's medical license number?
Dr. Konopaske holds Connecticut license 40112.
Which hospitals is Dr. Glenn Konopaske affiliated with?
Dr. Konopaske is affiliated with UConn John Dempsey Hospital.
What medical group is Dr. Glenn Konopaske part of?
Dr. Konopaske is linked to UConn Medical Group. Dmand AI links Dr. Konopaske to 3 more medical groups.
Does Dr. Glenn Konopaske accept Medicare?
Yes. CMS data shows Dr. Konopaske billed Medicare for 58 services in 2024, and Dr. Konopaske accepts Medicare assignment.
Does Dr. Glenn Konopaske offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Konopaske as offering telehealth services.
How many Medicare patients does Dr. Glenn Konopaske see?
CMS counts 52 Medicare patients who saw Dr. Konopaske in 2024, with an average age of 62.
What services does Dr. Glenn Konopaske bill to Medicare?
In 2024, Dr. Konopaske's most billed Medicare services were office visit, established patient (99214) and hospital inpatient care (99231).
Show 6 more questionsShow fewer questions
Where did Dr. Glenn Konopaske go to medical school?
Dr. Konopaske graduated from University of Connecticut School of Medicine in 1999.
What drugs does Dr. Glenn Konopaske prescribe most?
In 2024 Medicare Part D data, Dr. Konopaske's most prescribed drugs by claims were Trazodone HCl, Bupropion XL and Duloxetine HCl.
Has Dr. Glenn Konopaske received payments from drug or device companies?
CMS Open Payments shows $18 in general payments to Dr. Konopaske from 1 company from 2016 to 2016. The largest total came from Teva Pharmaceuticals USA, Inc.
How long has Dr. Glenn Konopaske been practicing?
Dr. Konopaske graduated from medical school in 1999, 27 years ago.
Does Dr. Glenn Konopaske do research?
Dmand AI links 12 publications to Dr. Konopaske, published from 2013 to 2018. Dr. Konopaske has worked on 1 clinical trial.
Who does Dr. Glenn Konopaske publish with?
Dr. Konopaske's most frequent co-authors are Rakesh Karmacharya, MD, PhD (1 shared paper), Perry Franklin Renshaw, MD, PhD (1 shared paper) and Evan Yale Snyder, MD, PhD (1 shared paper).
Selling to psychiatry practices?
See psychiatrists in Connecticut by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card